Keren Yizhak

14.4k total citations · 2 hit papers
28 papers, 3.1k citations indexed

About

Keren Yizhak is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Keren Yizhak has authored 28 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Keren Yizhak's work include Microbial Metabolic Engineering and Bioproduction (10 papers), Bioinformatics and Genomic Networks (9 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Keren Yizhak is often cited by papers focused on Microbial Metabolic Engineering and Bioproduction (10 papers), Bioinformatics and Genomic Networks (9 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Keren Yizhak collaborates with scholars based in Israel, United States and United Kingdom. Keren Yizhak's co-authors include Eytan Ruppin, William C. Faquin, Edmund A. Mroz, Christopher Rodman, Orit Rozenblatt–Rosen, Ravi Mylvaganam, B Bernstein, Anuraag S. Parikh, James W. Rocco and Itay Tirosh and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Keren Yizhak

25 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer

2017 1.5k citations Sidharth V. Puram, Itay Tirosh et al. Cell profile →
RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues

2019 310 citations Keren Yizhak, François Aguet et al. Science profile →

Peers

Countries citing papers authored by Keren Yizhak

Since Specialization

Citations

This map shows the geographic impact of Keren Yizhak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keren Yizhak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keren Yizhak more than expected).

Fields of papers citing papers by Keren Yizhak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keren Yizhak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keren Yizhak. The network helps show where Keren Yizhak may publish in the future.

Co-authorship network of co-authors of Keren Yizhak

This figure shows the co-authorship network connecting the top 25 collaborators of Keren Yizhak. A scholar is included among the top collaborators of Keren Yizhak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keren Yizhak. Keren Yizhak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-cell meta-analysis of T cells reveals clonal dynamics of response to checkpoint immunotherapy 2025 ·Cell Genomics ·(unknown), (unknown), Keren Yizhak	1
2	Unveiling alternative splicing dynamics in activated T lymphocytes and their implications for immune checkpoint blockade efficacy 2025 ·iScience ·(unknown), Otto Stern, (unknown), (unknown), Thomas Eisenhaure, Sarah E. Henrickson, Moshe Sade-Feldman, (unknown), Galit Eisenberg, Nir Hacohen, Keren Yizhak, Michal Lotem	0
3	Uncovering gene and cellular signatures of immune checkpoint response via machine learning and single-cell RNA-seq 2025 ·npj Precision Oncology ·(unknown), Keren Yizhak	0
4	Characterizing the tumor and immune landscape of patients with melanoma treated with combined checkpoint blockade and MAPK-targeted therapy. 2024 ·Journal of Clinical Oncology ·(unknown), Irena Gushterova, Thomas J. LaSalle, Emily M. Blaum, Tatyana Sharova, (unknown), Anita Giobbie‐Hurder, Moshe Sade-Feldman, Keren Yizhak, Nir Hacohen, Ryan J. Sullivan	1
5	A metabolic switch to the pentose-phosphate pathway induces radiation resistance in pancreatic cancer 2024 ·Radiotherapy and Oncology ·(unknown), Ifat Abramovich, (unknown), (unknown), Chani Stossel, Dikla Atias, (unknown), Keren Yizhak, Talia Golan, Eyal Gottlieb, Yaacov Richard Lawrence	3
6	Metabolic predictors of response to immune checkpoint blockade therapy 2023 ·iScience ·(unknown), Keren Yizhak	4
7	Estimating tumor mutational burden from RNA-sequencing without a matched-normal sample 2022 ·Nature Communications ·(unknown), (unknown), Keren Yizhak	9
8	Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions 2021 ·Cancer Immunology Research ·Emma Hajaj, (unknown), (unknown), Sharon Merims, Jonathan Cohen, Shiri Klein, Shoshana Frankenburg, Moshe Sade-Feldman, Yuval Tabach, Keren Yizhak, Ami Navon, Polina Stepensky, Nir Hacohen, Tamar Peretz, André Veillette, Rotem Karni, Galit Eisenberg, Michal Lotem	14
9	RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues breakdown → 2019 ·Science ·Keren Yizhak, François Aguet, Jaegil Kim, Julian M. Hess, Kirsten Kübler, Jonna Grimsby, (unknown), Hailei Zhang, Nicholas J. Haradhvala, Daniel Rosebrock, Dimitri Livitz, Xiao Li, (unknown), Noam Shoresh, Chip Stewart, Ayellet V. Segrè, Philip A. Branton, Paz Polak, Kristin Ardlie, Gad Getz	310
10	Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer breakdown → 2017 ·Cell ·Sidharth V. Puram, Itay Tirosh, Anuraag S. Parikh, Anoop P. Patel, Keren Yizhak, Shawn Gillespie, Christopher Rodman, (unknown), Edmund A. Mroz, Kevin S. Emerick, Daniel G. Deschler, Mark A. Varvares, Ravi Mylvaganam, Orit Rozenblatt–Rosen, James W. Rocco, William C. Faquin, Derrick T. Lin, Aviv Regev, B Bernstein	1547
11	An integrated computational and experimental study uncovers FUT 9 as a metabolic driver of colorectal cancer 2017 ·Molecular Systems Biology ·Noam Auslander, (unknown), Behzad M. Toosi, (unknown), Keren Yizhak, Frederick S. Vizeacoumar, Sreejith Parameswaran, N Gonen, Tanya Freywald, Kalpana K. Bhanumathy, Andrew Freywald, Franco J. Vizeacoumar, Eytan Ruppin	37
12	A joint analysis of transcriptomic and metabolomic data uncovers enhanced enzyme-metabolite coupling in breast cancer 2016 ·Scientific Reports ·Noam Auslander, Keren Yizhak, (unknown), Anuradha Budhu, Wei Tang, Xin Wei Wang, Stefan Ambs, Eytan Ruppin	41
13	Essential Genes Embody Increased Mutational Robustness to Compensate for the Lack of Backup Genetic Redundancy 2016 ·PLoS ONE ·(unknown), Matthew Oberhardt, Keren Yizhak, Eytan Ruppin	5
14	Modeling cancer metabolism on a genome scale 2015 ·Molecular Systems Biology ·Keren Yizhak, Barbara Chaneton, Eyal Gottlieb, Eytan Ruppin	131
15	Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis 2015 ·Nature ·Shiran Rabinovich, Lital N. Adler, Keren Yizhak, Alona Sarver, Alon Silberman, (unknown), Noa Stettner, Qin Sun, Alexander Brandis, Daniel Helbling, Stanley H. Korman, Shalev Itzkovitz, David Dimmock, Igor Ulitsky, Sandesh C.S. Nagamani, Eytan Ruppin, Ayelet Erez	264
16	Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer 2014 ·eLife ·Keren Yizhak, Edoardo Gaude, Sylvia E. Le Dévédec, Yedael Y. Waldman, Gideon Y. Stein, Bob van de Water, Christian Frezza, Eytan Ruppin	103
17	A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration 2014 ·Molecular Systems Biology ·Keren Yizhak, Sylvia E. Le Dévédec, (unknown), Franziska Baenke, Vincent C. J. de Boer, Christian Frezza, Almut Schulze, Bob van de Water, Eytan Ruppin	111
18	Model-based identification of drug targets that revert disrupted metabolism and its application to ageing 2013 ·Nature Communications ·Keren Yizhak, (unknown), Haim Cohen, Eytan Ruppin	66
19	p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production 2013 ·Cancer & Metabolism ·Ido Goldstein, Keren Yizhak, Shalom Madar, Naomi Goldfinger, Eytan Ruppin, Varda Rotter	64
20	Metabolically re-modeling the drug pipeline 2013 ·Current Opinion in Pharmacology ·Matthew Oberhardt, Keren Yizhak, Eytan Ruppin	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact